Common med provides a cheap and effective treatment in sub-Saharan Africa. Andrew Masterson reports.
Research raises hope for an eventual drug-free solution to intractable disease. Samantha Page reports.
The bacterium responsible for tuberculosis is evolving in response to HIV infection, with potentially serious implications for vaccine design. Paul Biegler reports.
As a major South African HIV vaccination trial gets underway a new study suggests its benefits could be undercut by vaccine-resistant strains. Paul Biegler reports.
An artist’s impression of a HIV virus particle in the bloodstream. Credit: Ian Cuming / Getty Images Human immunodeficiency virus causes acquired immunodeficiency syndrome which, through advancing failures of the immune system, allows life-threatening cancers and infections to thrive. Without treatment, people who contract AIDS typically survive for around three years, but currently antiretroviral therapy can … Continue reading Drug flushes HIV from cells
Meera Senthilingam reports on a groundbreaking medical trial in South Africa.